Smoking is down but why are more Hong Kong women getting lung cancer? - South China Morning Post
Smoking is down but why are more Hong Kong women getting lung cancer? South China Morning Post
Lung Cancer News
GSK to buy Nuvalent, maker of targeted cancer drugs, for $10.6B - statnews.com
GSK to buy Nuvalent, maker of targeted cancer drugs, for $10.6B statnews.com
Electronic cigarette use after smoking cessation and lung cancer risk - Nature
Electronic cigarette use after smoking cessation and lung cancer risk Nature
Idris Elba Says He Had 'a Tough Time' After His Father's Death from Lung Cancer: 'Changed My Life' - people.com
Idris Elba Says He Had 'a Tough Time' After His Father's Death from Lung Cancer: 'Changed My Life' people.com
One label, many risks: how grouping Asian Americans hides deadly cancer patterns - Los Angeles Times
One label, many risks: how grouping Asian Americans hides deadly cancer patterns Los Angeles Times
The KDM3A/METTL16/PDK1 axis: A novel prognostic biomarker and therapeutic target for TKI-resistant lung cancer - EurekAlert!
The KDM3A/METTL16/PDK1 axis: A novel prognostic biomarker and therapeutic target for TKI-resistant lung cancer EurekAlert!
GSK Agrees to Buy Nuvalent for $10.6 Billion - Bloomberg
GSK Agrees to Buy Nuvalent for $10.6 Billion Bloomberg
Blood test can predict lung cancer 5 years before diagnosis - The Times of India
Blood test can predict lung cancer 5 years before diagnosis The Times of India
GSK to buy US lung cancer drug specialist Nuvalent for £8bn - The Independent
GSK to buy US lung cancer drug specialist Nuvalent for £8bn The Independent
Texas Man Celebrates 100th Birthday After Defying Odds and Surviving Stage 4 Lung Cancer - people.com
Texas Man Celebrates 100th Birthday After Defying Odds and Surviving Stage 4 Lung Cancer people.com
Reducing Treatment Burden in Lung Cancer With Telehealth Visits For Extended Dosing of Pembrolizumab - Cancer Nursing Today
Reducing Treatment Burden in Lung Cancer With Telehealth Visits For Extended Dosing of Pembrolizumab Cancer Nursing Today
GSK boosts lung cancer portfolio with $10.6 billion Nuvalent takeover - Reuters
GSK boosts lung cancer portfolio with $10.6 billion Nuvalent takeover Reuters
GSK to buy Nuvalent for $10.6 billion, gaining trio of lung cancer drugs - FirstWord Pharma
GSK to buy Nuvalent for $10.6 billion, gaining trio of lung cancer drugs FirstWord Pharma
Lung cancer ‘Sunday Health Forum’ coming to Hattiesburg - WDAM-TV
Lung cancer ‘Sunday Health Forum’ coming to Hattiesburg WDAM-TV
Blood test spots 14 proteins that predict lung cancer risk up to five years early - Medical Xpress
Blood test spots 14 proteins that predict lung cancer risk up to five years early Medical Xpress
Early Research Suggests a Path to Predict and Prevent Lung Cancer - The New York Times
Early Research Suggests a Path to Predict and Prevent Lung Cancer The New York Times
Advanced Lung Cancer: First- vs. Second-Line Therapy - WebMD
Advanced Lung Cancer: First- vs. Second-Line Therapy WebMD
Blood Test Boosts Lung Cancer Screening Participation - Clinical Lab Products
Blood Test Boosts Lung Cancer Screening Participation Clinical Lab Products
Borderline Resectable NSCLC: Challenges and Treatment Approaches - Oncology News Central
Borderline Resectable NSCLC: Challenges and Treatment Approaches Oncology News Central
Retired San Francisco firefighter Ken Jones dies from lung cancer being denied treatment by Blue Shield - ABC7 Bay Area
Retired San Francisco firefighter Ken Jones dies from lung cancer being denied treatment by Blue Shield ABC7 Bay Area
LUCAS to offer lung cancer screening in Princeton, Gary, and Ravenswood - WV News
LUCAS to offer lung cancer screening in Princeton, Gary, and Ravenswood WV News
Helena Linardou: AI in Lung Cancer at ESTS 2026 - Oncodaily
Helena Linardou: AI in Lung Cancer at ESTS 2026 Oncodaily
Tarlatamab Receives EU Approval in Extensive-Stage Small Cell Lung Cancer - CancerNetwork
Tarlatamab Receives EU Approval in Extensive-Stage Small Cell Lung Cancer CancerNetwork
Blood Test May Predict Lung Cancer Risk 5 Years Before Diagnosis: Study - NDTV
Blood Test May Predict Lung Cancer Risk 5 Years Before Diagnosis: Study NDTV
Gilead's lung cancer bid for Trodelvy hits wall, but HIV studies deliver better news - FirstWord Pharma
Gilead's lung cancer bid for Trodelvy hits wall, but HIV studies deliver better news FirstWord Pharma
Metabolic switch in lung cancer reprograms immune cells to slow tumors - Medical Xpress
Metabolic switch in lung cancer reprograms immune cells to slow tumors Medical Xpress
Early-Stage NSCLC: New Standards and Controversies in Care - Oncology News Central
Early-Stage NSCLC: New Standards and Controversies in Care Oncology News Central
Blood-Based Risk Score Could Enable Earlier Lung Cancer Prevention - Inside Precision Medicine
Blood-Based Risk Score Could Enable Earlier Lung Cancer Prevention Inside Precision Medicine
New Research Suggests a Possible Path to Prevent Lung Cancer - The New York Times
New Research Suggests a Possible Path to Prevent Lung Cancer The New York Times
Evolving strategies in lung cancer management - Mayo Clinic
Evolving strategies in lung cancer management Mayo Clinic
Merck and Gilead discontinue lung cancer drug trial - Investing.com
Merck and Gilead discontinue lung cancer drug trial Investing.com
Reducing Hospital Admissions and ED Visits in Lung Cancer Care With Nurse Navigation Strategies - Cancer Nursing Today
Reducing Hospital Admissions and ED Visits in Lung Cancer Care With Nurse Navigation Strategies Cancer Nursing Today
High Hopes, Hard Reality: Merck and Gilead's Lung Cancer Combo Trial Falters - BriefGlance
High Hopes, Hard Reality: Merck and Gilead's Lung Cancer Combo Trial Falters BriefGlance
Targeted therapy reduces risk of lung cancer recurrence by 83% in rare genetic subtype - UCLA Health
Targeted therapy reduces risk of lung cancer recurrence by 83% in rare genetic subtype UCLA Health
E-bike safety; lung cancer treatment and prevention; keeping CMA Festival attendees safe; plus other stories with Vanderbilt Health sources - Vanderbilt Health News
E-bike safety; lung cancer treatment and prevention; keeping CMA Festival attendees safe; plus other stories with Vanderbilt Health sources Vanderbilt Health News
Regan Memmott, MD, PhD, Discusses Trial Exploring Osimertinib Plus Tegavivint in Patients with NSCLC - Cancer Nursing Today
Regan Memmott, MD, PhD, Discusses Trial Exploring Osimertinib Plus Tegavivint in Patients with NSCLC Cancer Nursing Today
GSK agreed to buy Nuvalent for $10.6bn to expand lung cancer treatments - mezha.net
GSK agreed to buy Nuvalent for $10.6bn to expand lung cancer treatments mezha.net
'They went through my vocal cords': Barry Manilow recovers after lung cancer surgery - NPR
'They went through my vocal cords': Barry Manilow recovers after lung cancer surgery NPR
Daneng Li, MD, on Tegavivint in Advanced HCC - The ASCO Post
Daneng Li, MD, on Tegavivint in Advanced HCC The ASCO Post
Lung Cancer in Women as a Distinct and Underserved Malignancy – Lung Cancer Europe - Oncodaily
Lung Cancer in Women as a Distinct and Underserved Malignancy – Lung Cancer Europe Oncodaily